Fly Insider: Fate Therapeutics, Atlassian among week’s notable insider trades

Atlassian CEO Farquhar sold $1.4M in company shares, while a Fate holder purchased $4.29M in shares

Welcome to "Fly Insider," The Fly’s weekly recap of notable insider stock transactions.

NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from April 17 through April 21 include:

• Shareholder of Ambrx Biopharma (AMAM) Cormorant Asset Management purchased 2,597,896 shares of company stock at $9.75 per share for a total transaction amount of $25,319,354

• Director of Lovesac (LOVE) Sharon Leite purchased 5,000 shares of company stock at $28.55 per share for a total transaction amount of $142,750

• Shareholder of Frontier Communications (FYBR) Ares purchased 200,000 shares of company stock at $21.44 per share for a total transaction amount of $4,288,020

• Shareholder of Fate Therapeutics (FATE) Redmile Group purchased 276,639 shares of company stock at $6.17 per share for a total transaction amount of $1,705,839

NOTABLE INSIDER SALES: Significant insider sales in the prior week from from from April 17 through April 21 include:

• CFO of Apple (AAPL) Luca Maestri sold 69,996 shares of company stock at $165.25 per share for a total transaction amount of $11,566,839

• Chairman of Coursera (COUR) Andrew Ng sold 75,000 shares of company stock at $10.49 per share for a total transaction amount of $786,788
• Beneficial Owner of Garrett Motion (GTX) Cyrus Capital sold 163,612 shares of company stock at $8.21 per share for a total transaction amount of $1,343,582

• CEO of Atlassian (TEAM) Scott Farquhar sold 8,614 shares of company stock at $162.31 per share for a total transaction amount of $1,398,160

NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Fate Therapeutics moved up over 4% after shareholder Redmile Group purchased 276,639 shares of company stock at $6.17 per share, while shares of Atlassian moved lower by approximately 4% after CEO Scott Farquhar sold 8,614 shares of company stock at $162.31 per share.

Keywords: insider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC